141 related articles for article (PubMed ID: 8583857)
1. Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma.
Bujía J; Kim C; Boyle D; Hammer C; Firestein G; Kastenbauer E
Laryngoscope; 1996 Feb; 106(2 Pt 1):217-20. PubMed ID: 8583857
[TBL] [Abstract][Full Text] [Related]
2. [The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma].
Liu J; Lin G; Huang J; Jiang Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):30-3. PubMed ID: 12768791
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression.
Bujía J; Kim C; Holly A; Sudhoff H; Ostos P; Kastenbauer E
Am J Otol; 1996 Mar; 17(2):203-6. PubMed ID: 8723947
[TBL] [Abstract][Full Text] [Related]
4. Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma.
Kojima H; Shiwa M; Kamide Y; Moriyama H
Acta Otolaryngol; 1994 Jul; 114(4):423-9. PubMed ID: 7976315
[TBL] [Abstract][Full Text] [Related]
5. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
Schilling V; Negri B; Bujía J; Schulz P; Kastenbauer E
Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.
Holly A; Sittinger M; Bujia J
Eur Arch Otorhinolaryngol; 1995; 252(6):366-9. PubMed ID: 8679157
[TBL] [Abstract][Full Text] [Related]
7. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
[TBL] [Abstract][Full Text] [Related]
8. [The roles of interleukin-1 alpha, tumor necrosis factor-alpha and parathyroid hormone-related protein in bone resorption of cholesteatoma otitis].
Kinoshita K
Nihon Jibiinkoka Gakkai Kaiho; 1994 Aug; 97(8):1472-80. PubMed ID: 7931803
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of placenta growth factor in human middle ear cholesteatoma.
Cho JG; Lim HW; Woo JS; Hwang SJ; Lee HM; Chae SW
Acta Otolaryngol; 2006 Sep; 126(9):900-4. PubMed ID: 16864484
[TBL] [Abstract][Full Text] [Related]
10. [Expression of metallothionein 2 in middle ear cholesteatoma and its correlation with interleukin 1α and interleukin 6].
Liu Y; Yu LL; Han J; Cheng JN; Yang DZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):831-5. PubMed ID: 23302165
[TBL] [Abstract][Full Text] [Related]
11. Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas.
Bujía J; Kim C; Ostos P; Kastenbauer E; Hültner L
Eur Arch Otorhinolaryngol; 1996; 253(3):152-7. PubMed ID: 8652157
[TBL] [Abstract][Full Text] [Related]
12. Expression of transforming growth factor-alpha (TGF-alpha) in cholesteatoma.
Shiwa M; Kojima H; Moriyama H
J Laryngol Otol; 1998 Aug; 112(8):750-4. PubMed ID: 9850316
[TBL] [Abstract][Full Text] [Related]
13. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma.
Yetiser S; Satar B; Aydin N
Otol Neurotol; 2002 Sep; 23(5):647-52. PubMed ID: 12218613
[TBL] [Abstract][Full Text] [Related]
14. Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium.
Kojima H; Miyazaki H; Tanaka Y; Shiwa M; Koga T; Moriyama H
Arch Otolaryngol Head Neck Surg; 1999 Jul; 125(7):738-42. PubMed ID: 10406309
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity.
Bujía J; Kim C; Ostos P; Sudhoff H; Kastenbauer E; Hültner L
Eur Arch Otorhinolaryngol; 1996; 253(4-5):252-5. PubMed ID: 8737779
[TBL] [Abstract][Full Text] [Related]
16. [Study of long non-coding RNA HOTAIR expression in middle ear cholesteatoma].
Li Q; Wang HQ; Chen YQ; Xiong S; Zeng L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(4):250-253. PubMed ID: 29871236
[No Abstract] [Full Text] [Related]
17. Enhanced epithelial proliferation due to elevated levels of interleukin-1 receptors in middle ear cholesteatomas.
Bujia J; Kim C; Ostos-Aumente P; Lopez-Villarejo J; Kastenbauer E
Eur Arch Otorhinolaryngol; 1997; 254(1):6-8. PubMed ID: 9115708
[TBL] [Abstract][Full Text] [Related]
18. Expression of bone morphogenetic protein-2 messenger ribonucleic acid in cholesteatoma fibroblasts.
Schmidt M; Schler G; Gruensfelder P; Hoppe F
Otol Neurotol; 2002 May; 23(3):267-70. PubMed ID: 11981380
[TBL] [Abstract][Full Text] [Related]
19. [Interleukin-1-containing cells in cholesteatoma of the middle ear].
Schilling V; Bujia J; Negri B; Kastenbauer E
Laryngorhinootologie; 1992 May; 71(5):271-5. PubMed ID: 1616549
[TBL] [Abstract][Full Text] [Related]
20. Involvement of interleukin-1 in middle ear cholesteatoma.
Shiwa M; Kojima H; Kamide Y; Moriyama H
Am J Otolaryngol; 1995; 16(5):319-24. PubMed ID: 7503375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
